A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam

Conclusion: Our study identified potential signals of new AEs that could provide strong support for clinical monitoring and risk identification of diazepam.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research